Biliary inflammation reduced by IBD drug

BARCELONA – The monoclonal antibody vedolizumab may reduce biliary inflammation in patients with primary sclerosing cholangitis and comorbid inflammatory bowel disease, according to early, open-label...
Source: Family Practice News - Category: Primary Care Source Type: news